Gulam Jaffer
Clinical trials are increasingly global and include both traditional structures and newer siteless models with direct-to- and direct-from-patient delivery capabilities. Sponsor companies and ...
Shaonly Saha
Successful and rapid analytical method development plays a key role in ensuring the development of robust processes to produce high-quality products. When standard or predefined methods fail ...
Julie Risdon
Investors expect pharmaceutical companies to meet commercialization timelines, and failure to do so can have significant financial consequences. Contract development and manufacturing ...
Tyler Ewald
The key to success for pharmaceutical contract development and manufacturing organizations (CDMOs) is to understand the needs of the market and evolve the business to ensure that it can always ...
Ian Markwell
Almac Pharma Services successfully completed global regulatory GMP inspections at three different sites within two weeks, a milestone that reflects the company’s commitment to quality and global ...
Vincent Minvielle
Since its founding, Servier has adopted a patient-centric focus and has been committed to producing high-quality drugs while simultaneously providing a positive work environment for its ...
Alex Weaver
PCI Pharma Services has invested heavily in expanding capabilities to meet the growing need for parenteral packaging services to support a range of products from niche, personalized medicines to ...
Tim Tench
Ensuring that patients receive novel medicines is a key driver for working to reduce the time it takes to design and build a new biopharmaceutical facility. Despite the complexity of biopharma ...
Bernie Sweeney
The pharmaceutical industry is increasingly focused on the development of next-generation drug products that allow the targeted delivery of active ingredients with multiple functionalities, ...
Laura Towart
There’s a quiet revolution taking place in medical research, and it only depends upon combining familiar, existing technologies in just the right way. The Evolution of Personalized Medicine ...
George Hlass
Switching from an early-phase CDMO to a commercial-scale manufacturer for your highly potent active pharmaceutical ingredient (HPAPI) projects can be costly and lead to project delays. ...
Philipp Spycher
Novel linker technology enables the rapid development and manufacture of highly stable antibody–drug conjugates (ADCs) with improved safety and efficacy. Targeted Nature Drives Interest in ADCs ...
Justin Kadis
The main goal of the pharmaceutical industry is to get drugs into the hands of the patients who need them as quickly as possible. Especially for new drugs, or for those that address conditions ...
Peter Scholes
Quotient Sciences has been employing its unique Translational Pharmaceutics® integrated platform to accelerate product development for more than a decade. This platform has significantly reduced ...
Richard Richieri
With an expert process development (PD) team and a new, state-of-the-art PD lab and pilot-scale facility, Avid Bioservices is well positioned to support projects from concept to ...
Robert Reames
Plasmid DNA was key to the development of biologic drug manufacturing. Today, it plays a critical role in the production of next-generation cell and gene therapies and vaccines. With its plasmid ...
Marga Viñes
Developing cost-effective manufacturing solutions for smaller volumes of highly specialized orphan drugs can be challenging, particularly for small and emerging pharmaceutical companies seeking ...
Haig Armaghanian
The biosimilars market in the United States continues to lag behind the rest of the world. However, there are promising signs that the market is poised to gain momentum. Expanding Biosimilars ...
Richard Snyder, Ph.D.
INDUSTRY LEADER INSIGHT Adeno-associated viral (AAV) vectors are currently the most widely used gene transfer vectors in many gene therapies that are in development. Two commercial products, ...
Gulam Jaffer
The number and complexity of clinical trials is increasing dramatically. While trials tend to enroll fewer patients, those patients are often in remote locations and increasingly prefer to be ...
Kim Berger
When selecting a contract development and manufacturing organization (CDMO), companies typically place the greatest emphasis on price, quality and capabilities, but do not always appropriately ...
James J. Springer
Technical expertise and access to state-of-the-art equipment and facilities are necessary but insufficient for successful completion of small molecule API technology transfer projects. Contract ...
Jeffrey Marlough
Private equity firms create incentives to retain management teams that create value in their invested companies. Need to Incentivize When private equity (PE) firms invest, they want to ensure ...
Stuart E. Needleman
A truly integrated CDMO with the right structural foundation and top-down commitment can provide tremendous benefits to biopharmaceutical customers. Rising Demand for Contract Services The value ...
Robert N. White III
Semisolid drugs have advantages over other dosage forms, from limited side effects to ease of use. However, semisolid drugs require special expertise and experience to ensure optimal production ...
Suzanne Greene
With the addition of OEB level 5 drug product manufacturing capabilities at its Arklow, Ireland site, Servier is positioned to provide high-containment contract services for commercial ...
Christa Myers
From personalized therapies to Big Data and digitalization, key trends in technology are driving new strategies for pharmaceutical facility design and construction. Greater Focus on Patient ...
Lorraine Hill
From pre-filled syringes to oral contraceptives to eyedrops, Aspen Pharmacare has a global network of highly integrated and advanced centers of manufacturing excellence. With a commitment to ...
Laura Towart
Tumor adaptability is determined by genetic mutations that are different for each patient. Identifying the optimum combination of chemotherapies and non-cancer drugs for each patient requires ...
Shawn Singh
Major depressive disorder (MDD) and social anxiety disorder (SAD) are two common mental health conditions for which effective treatments are currently lacking. Dramatic increases in both ...
Michael Scholl
Stabilization and protection of biomolecules enables development of formulations that exhibit optimal product characteristics, increasing shelf life, reducing the cold-chain burden, enabling ...
Nice Insight
Company Profile | BioVectra BioVectra is headquartered on a picturesque island that affords all the comforts of home. BioVectra has two locations in this region, one in Charlottetown, ...
Daniel P. Slone
By considering evolving client needs across operations Samsung BioLogics has rapidly become a leading biopharmaceutical CDMO. Providing Fully Integrated Solutions Samsung BioLogics began as a ...
Kevin McLean
Even at low frequency occurrence, glass vial breakage during a lyophilization cycle is a serious issue. Traditional molded glass vials are heavier and more resistant to breakage, however still ...
Vladas Algirdas Bumelis
Northway Biotechpharma, a leading biopharmaceutical contract development and manufacturing organization (CDMO), celebrated its 15th anniversary on July 16, 2019. As a midsized CDMO, Northway ...
Our fourth quarter edition features leading insights from subject matter experts covering a range of cutting-edge scientific topics, including microbiome therapy, biofabrication, cell and gene therapy, antibody–drug conjugates (ADCs), high-potency APIs, next-generation chromatography, personalized medicine and the increasingly complex “zoo” of multifunctional antibody and protein formats.
Download Current IssueAbbVie and Scripps Research Announce Collaboration to Develop a Broad Range of New Therapeutics
Check out the top 100 articles and trending topics our subscribers are reading right now.
Discover which PA contributors have had the most readers.
Find out which companies have been viewed the most in each industry segment.
View more about the industry-leading companies who contributed to Pharma's Almanac in 2019.
View Full Company Directory